| Nome |
# |
|
Gaucher Disease and Myelofibrosis: A Combined Disease or a Misdiagnosis?, file e383531d-83c2-15e8-e053-a505fe0a3de9
|
306
|
|
Long-term efficacy and safety results of taliglucerase alfa through 5years in adult treatment-naïve patients with Gaucher disease, file e3835315-f7b1-15e8-e053-a505fe0a3de9
|
154
|
|
Atypical chronic myeloid leukemia in a patient with aplastic anemia, file e3835321-da0d-15e8-e053-a505fe0a3de9
|
132
|
|
A case of motor neuron involvement in Gaucher disease, file e3835323-e76f-15e8-e053-a505fe0a3de9
|
117
|
|
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis, file e3835321-9cba-15e8-e053-a505fe0a3de9
|
112
|
|
Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib, file e383531d-3be6-15e8-e053-a505fe0a3de9
|
103
|
|
Long-term follow-up of Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in children and adolescents managed at a single institution over a 20-year period, file e383531b-b692-15e8-e053-a505fe0a3de9
|
98
|
|
Twenty years of the Italian Fanconi Anemia Registry: Where we stand and what remains to be learned, file e3835315-fb1c-15e8-e053-a505fe0a3de9
|
92
|
|
Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease, file e3835315-d312-15e8-e053-a505fe0a3de9
|
79
|
|
Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia, file e3835324-c2e0-15e8-e053-a505fe0a3de9
|
74
|
|
Use of eltrombopag in children with chronic immune thrombocytopenia (ITP): a real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP), file e3835324-caf3-15e8-e053-a505fe0a3de9
|
62
|
|
Salivary test assessment in an oncohematological pediatric sample: a case control study, file e383532e-b647-15e8-e053-a505fe0a3de9
|
28
|
|
The Spectrum of Neurological and Sensory Abnormalities in Gaucher Disease Patients: A Multidisciplinary Study (SENOPRO), file 8e37426d-b25f-450d-8e7b-71c8857c885f
|
20
|
|
Immune dysregulation in Kabuki syndrome. a case report of Evans syndrome and hypogammaglobulinemia, file 1cb53c90-7bc0-48b8-9aa5-7a41cd64c9c9
|
17
|
|
Parkinson's disease in Gaucher disease patients: What's changing in the counseling and management of patients and their relatives?, file e3835328-4608-15e8-e053-a505fe0a3de9
|
14
|
|
Advanced mast cell disease: an Italian Hematological Multicenter experience, file e3835312-0106-15e8-e053-a505fe0a3de9
|
11
|
|
Low bone density, slowed growth rate, gynecomastia and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty., file e3835311-9b6b-15e8-e053-a505fe0a3de9
|
10
|
|
Mast cell leukemia: a report of ten cases., file e3835311-9499-15e8-e053-a505fe0a3de9
|
9
|
|
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia, file e3835311-5111-15e8-e053-a505fe0a3de9
|
8
|
|
Risultati preliminari degli Studi Prospettico e Retrospettivo (OEP 2015-01 e 2015-02) sull’Anemia Emolitica Autoimmune (AEA) del bambino di nuova diagnosi, file e3835328-21d9-15e8-e053-a505fe0a3de9
|
8
|
|
Conservative management of priapism secondary to leukemia, file e3835312-084a-15e8-e053-a505fe0a3de9
|
7
|
|
Thrombopoietin Receptor Activation, Thrombopoietin Mimetic Drugs, and Hereditary Thrombocytosis: Remarks on Bone Marrow Fibrosis., file e3835311-7083-15e8-e053-a505fe0a3de9
|
6
|
|
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia, file e3835324-bc70-15e8-e053-a505fe0a3de9
|
6
|
|
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis., file e3835311-553d-15e8-e053-a505fe0a3de9
|
5
|
|
Childhood polycythemia vera and essential thrombocythemia: Does their pathogenesis overlap with that of adult patients?, file e3835311-5566-15e8-e053-a505fe0a3de9
|
5
|
|
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia., file e383531a-3055-15e8-e053-a505fe0a3de9
|
5
|
|
ETV6-related thrombocytopenia: dominant negative effect of mutations as common pathogenic mechanism, file 320651ec-83a2-4779-83ca-229cbdb158c4
|
4
|
|
Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian gaucher patients., file e3835312-19d0-15e8-e053-a505fe0a3de9
|
4
|
|
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis., file e3835312-1be7-15e8-e053-a505fe0a3de9
|
4
|
|
Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two italian centres. Clin Microbiol Infect. 2005; 11: 505-7., file e3835321-066a-15e8-e053-a505fe0a3de9
|
4
|
|
Thrombopoietin receptor agonist use,efficacy and toxicity in children with immune thrombocytopenia: data from an Italian multicenter survey, file e3835322-1cb7-15e8-e053-a505fe0a3de9
|
4
|
|
Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience., file e3835322-1fd8-15e8-e053-a505fe0a3de9
|
4
|
|
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome, file e3835311-fd31-15e8-e053-a505fe0a3de9
|
3
|
|
Non-invasive ventilation for severe TRALI and myocardial stunning: Report and literature review, file e3835311-fdda-15e8-e053-a505fe0a3de9
|
3
|
|
The mutant JAK2(V617F) allele burden in children with essential thrombocythemia, file e3835312-0104-15e8-e053-a505fe0a3de9
|
3
|
|
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia, file e3835312-0848-15e8-e053-a505fe0a3de9
|
3
|
|
Pivotal trial with plant-cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease., file e3835312-1a77-15e8-e053-a505fe0a3de9
|
3
|
|
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group., file e3835312-34fb-15e8-e053-a505fe0a3de9
|
3
|
|
Leptin modification in chronic myeloid leukemia patients treated with imatinib: An emerging effect of targeted therapy, file e3835312-57b7-15e8-e053-a505fe0a3de9
|
3
|
|
Successful management of a chronic refractory leg ulcer in an adolescent with sickle cell anemia, file e3835316-1eae-15e8-e053-a505fe0a3de9
|
3
|
|
Next-Generation Sequencing (NGS) in childhood Myeloproliferative Diseases (MPD), file e3835321-d555-15e8-e053-a505fe0a3de9
|
3
|
|
Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience, file e3835321-d843-15e8-e053-a505fe0a3de9
|
3
|
|
Intermittent Imatinib mesylate in children with chronic myeloid leukemia: results and outcome, file e3835321-fb3b-15e8-e053-a505fe0a3de9
|
3
|
|
null, file e3835322-2e11-15e8-e053-a505fe0a3de9
|
3
|
|
Multidisciplinary study based on clinical, electrophysiological and psychological evaluation combined with advanced neuro imaging in Gaucher disease patients, file e3835327-4136-15e8-e053-a505fe0a3de9
|
3
|
|
Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty., file e3835311-f13e-15e8-e053-a505fe0a3de9
|
2
|
|
A new severity score index for phenotypic classification and evaluation of response to treatment in type I Gaucher disease, file e3835312-0858-15e8-e053-a505fe0a3de9
|
2
|
|
Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP), file e3835321-d2d6-15e8-e053-a505fe0a3de9
|
2
|
|
Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience, file e3835321-f3bb-15e8-e053-a505fe0a3de9
|
2
|
|
99mTc-sestamibi scintigraphy to monitor the long-term efficacy of enzyme replacement therapy on bone marrow infiltration in patients with gaucher disease, file e3835321-f5f4-15e8-e053-a505fe0a3de9
|
2
|
|
Management of Chronic Myeloid Leukemia in children and adolescents according to local guidelines the Italian experience, file e3835321-fb39-15e8-e053-a505fe0a3de9
|
2
|
|
The different dermoscopic features of the yellow background in Langerhans and non-Langerhans cells histiocytosis, file e3835322-0679-15e8-e053-a505fe0a3de9
|
2
|
|
Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia., file e3835322-1b28-15e8-e053-a505fe0a3de9
|
2
|
|
Management goals for type 1 Gaucher disease: a consensus document from the European Working Group on Gaucher Disease., file e3835322-307c-15e8-e053-a505fe0a3de9
|
2
|
|
Indomethacin is an effective treatment in adults and children with bone Langerhans cell histiocytosis (LCH), file e3835327-deff-15e8-e053-a505fe0a3de9
|
2
|
|
Trombocitopenia Idiopatica (ITP) cronica. cosa puo’ nascondere?, file e3835328-237a-15e8-e053-a505fe0a3de9
|
2
|
|
A long-term outcome for patients with high-risk leukemia undergoing an unrelated cord blood transplant (CBT), file e383532b-2051-15e8-e053-a505fe0a3de9
|
2
|
|
GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children., file e3835311-a457-15e8-e053-a505fe0a3de9
|
1
|
|
Langerhans Cell Histiocytosis With Orbital Involvement: Our Experience, file e3835312-0105-15e8-e053-a505fe0a3de9
|
1
|
|
Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT)., file e3835312-0113-15e8-e053-a505fe0a3de9
|
1
|
|
INIBITORI DI TIROSIN-CHINASI IN ONCOEMATOLOGIA, file e383531d-764b-15e8-e053-a505fe0a3de9
|
1
|
|
Home-based service for enzyme replacement therapy in lysosomal storage disorders: patient reported outcomes, file e3835321-7818-15e8-e053-a505fe0a3de9
|
1
|
|
ITP-QoL questionnaire for children with immune thrombocytopenia: Italian version validation's, file e3835321-c631-15e8-e053-a505fe0a3de9
|
1
|
|
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: A multicentric, real life study, file e3835321-c850-15e8-e053-a505fe0a3de9
|
1
|
|
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview, file e3835321-e476-15e8-e053-a505fe0a3de9
|
1
|
|
The Italian Mastocytosis Registry: a 6-year experience of a hospital-based registry., file e3835321-f1fe-15e8-e053-a505fe0a3de9
|
1
|
|
Early diagnosis of Gaucher disease in pediatric patients: Proposal for a diagnostic algorithm, file e3835322-07f4-15e8-e053-a505fe0a3de9
|
1
|
|
Standardization of MRI and Scintigraphic Scores for Assessing the Severity of Bone Marrow Involvement in Adult Patients with Type 1 Gaucher Disease., file e3835322-2a8e-15e8-e053-a505fe0a3de9
|
1
|
|
CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence., file e3835322-313e-15e8-e053-a505fe0a3de9
|
1
|
|
Multiple granuloma faciale: A clinical finding from a dermoscopic point a view, file e3835322-cd9c-15e8-e053-a505fe0a3de9
|
1
|
|
Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica), file e3835325-03b0-15e8-e053-a505fe0a3de9
|
1
|
|
Mast cell disorders, melanoma and pancreatic carcinoma: from a clinical observation to a brief review of the literature, file e3835327-41cc-15e8-e053-a505fe0a3de9
|
1
|
|
Specific guidelines including multidisciplinary approach is critical of management of Langerhans Cell Histiocytosis in adults, file e3835327-5d0b-15e8-e053-a505fe0a3de9
|
1
|
|
Accesso al Pronto Soccorso: una survey tra i pazienti con Malattia Drepanocitica seguiti presso i centri AIEOP, file e3835328-0ef7-15e8-e053-a505fe0a3de9
|
1
|
|
LOCALIZZAZIONE EXTRAMIDOLLARE DI LAM IN ETÀ PEDIATRICA: IL RUOLO DI UNA CORRETTA E TEMPESTIVA DIAGNOSI, file e3835328-10ae-15e8-e053-a505fe0a3de9
|
1
|
|
UTILIZZO DELL’ELTROMBOPAG NELLA “REAL LIFE” DEI BAMBINI AFFETTI DA TROMBOCITOPENIA IMMUNE CRONICA (ITP): ESPERIENZA MULTICENTRICA DELLA ASSOCIAZIONE ITALIANA DI EMATOLOGIA ED ONCOLOGIA PEDIATRICA (AIEOP), file e3835328-2378-15e8-e053-a505fe0a3de9
|
1
|
|
null, file e3835328-2383-15e8-e053-a505fe0a3de9
|
1
|
|
Esperienza con l'imatinib ad intermittenza nei bambini e adolescenti con leucemia mieloide cronica (LMC): risultati e prospettive, file e3835328-2386-15e8-e053-a505fe0a3de9
|
1
|
|
Multi-parameter neurological study based on combined conventional and functional assessments in Gaucher disease patients (SENOPRO_GAUCHER Study), file e3835328-450e-15e8-e053-a505fe0a3de9
|
1
|
|
EFFICACIA DEL PEG-IFNΑ-2A IN UN CASO DI POLICITEMIA VERA PEDIATRICA, file e3835328-50ab-15e8-e053-a505fe0a3de9
|
1
|
|
Polyostotic Fibrous Dysplasia Mimicking Bone Involvement in Hodgkin Lymphoma: A Pediatric Case and Literature Review, file e383532d-120b-15e8-e053-a505fe0a3de9
|
1
|
| Totale |
1.599 |